T-Cell and NK-Cell Neoplasm — Trials

T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,103 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 801–850 of 1,103 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04061772	A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma	unknown	Phase 2	54	Zhejiang Cancer HospitalOTHER	1	Aug 20, 2019	clinicaltrials
NCT01676831	Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)	completed	Phase 1 / Phase 2	13	Abramson Cancer Center at Penn MedicineOTHER	1	Aug 13, 2019	clinicaltrials